Recruiting Breast Cancer Studies in Lincoln
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Researchers are looking for new ways to treat types of breast cancer that are both: * High-risk, which means the cancer may have a higher chance of getting worse or coming back after treatment * Earl...
DNA-guided Second Line Adjuvant Therapy for High Residual Risk, Estrogen Receptor Positive, HER-2 Negative Breast Cancer (DARE)
A randomized, Phase II trial of circulating tumor DNA-guided second line Adjuvant therapy for high Residual risk, Estrogen Receptor positive, HER-2 negative breast cancer (DARE)...
About Breast Cancer Clinical Trials in Lincoln
Breast cancer is a disease in which cells in the breast grow out of control. It is the most common cancer in women worldwide and can also occur in men. Treatment options include surgery, radiation, chemotherapy, hormone therapy, and targeted therapies.
There are currently 2 breast cancer clinical trials recruiting participants in Lincoln, NE. These studies are seeking a combined 2,470 participants. Research is being sponsored by Merck Sharp & Dohme LLC, Criterium, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Breast Cancer Clinical Trials in Lincoln — FAQ
Are there breast cancer clinical trials in Lincoln?
Yes, there are 2 breast cancer clinical trials currently recruiting in Lincoln, NE. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Lincoln?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Lincoln research site will contact you about next steps.
Are clinical trials in Lincoln free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Lincoln studies also compensate for your time and travel.
What breast cancer treatments are being tested?
The 2 active trials in Lincoln are testing new therapies including novel drugs, biologics, and treatment approaches for breast cancer.
Data updated March 2, 2026 from ClinicalTrials.gov